(lp0
S'Buy or Sell? Average Brokerage Ratings on Merrimack Pharmaceuticals, Inc ... StockNewsJournal - 16 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p1
aS'Company Update : Merrimack Pharmaceuticals Inc Announces 4Q and ... Smarter Analyst - Mar 1, 2017 Merrimack Pharmaceuticals, Inc. engages in discovering, developing and preparing to commercialize innovative medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer.Merrimack Pharmaceuticals Inc.: Merrimack Reports Fourth Quarter and Full-Year ... - The Wall Street TranscriptMerrimack Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 01 - Equities.com'
p2
aS'Merrimack Pharmaceuticals Inc.  Plunges 5.92% on March 21 Equities.com - Mar 21, 2017 Merrimack Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 5.92%, or a loss of $-0.19 per share, to close at $3.02.'
p3
aS'Stock Returns: Geron Corporation  is Beating Merrimack ... CML News - 17 hours ago This is a snapshot to compare the stock returns for Geron Corporation  versus Merrimack Pharmaceuticals Inc  .'
p4
aS'Earnings Reaction History: Merrimack Pharmaceuticals Inc, 36.4% Follow-Through ... Nasdaq - Mar 1, 2017 Merrimack Pharmaceuticals Inc  is due to issue its quarterly earnings report in the upcoming extended-hours session.'
p5
aS'Analysts mean rating score stands at 2.50 while Merrimack Pharmaceuticals, Inc ... Hot Stocks Point - 16 hours ago Merrimack Pharmaceuticals, Inc.  stock price ended its day with loss -5.92% and finalized at the price of $3.02.'
p6
aS'Merrimack Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 17 Equities.com - Mar 17, 2017 Merrimack Pharmaceuticals Inc.  traded on unusually high volume on Mar. 17, as the stock lost 3.6% to close at $3.21.Fmr LLC Boosts Stake in Merrimack Pharmaceuticals Inc  - Chaffey BreezeMerrimack Pharmaceuticals  Stock: Gaining On Takeover Rumors - CNA Finance '
p7
aS'Merrimack Pharmaceuticals Inc.: Merrimack Announces Timing of Fourth Quarter ... The Wall Street Transcript - Feb 22, 2017 CAMBRIDGE, Mass., Feb. 22, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.  today announced that the company will host its Fourth Quarter 2016 investor conference call and webcast at 8:30 a.m.Merrimack Pharmaceuticals, Inc.  Scheduled to Post Earnings on Thursday - The Cerbat GemBiotech Stocks Worth a Closer Look: Merrimack Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar'
p8
aS'The Finish Line, Inc. , Merrimack Pharmaceuticals, Inc.  Stock ... The USA Commerce - Mar 21, 2017 The share price is now down -26.23% for the past three months. Latest closing price was -2.25% below its 50-day moving average and -17.73% below its 200-day moving average.Watching the Next Move of Merrimack Pharmaceuticals, Inc.  - The Oracle ExaminerMerrimack Pharmaceuticals, Inc.  hit its 52 Week low of $2.83 on Jan 23 ... - The Newburgh Press'
p9
aS'Merrimack Pharmaceuticals, Inc.  Technical Analysis: Support and ... USA Commerce Daily - 13 hours ago With all other things going on, Merrimack Pharmaceuticals, Inc.  has been on a free fall - declining -41.81 percent in just three months.'
p10
a.